COVID-19近两年:抗生素使用的某些方面

Q4 Medicine

Klinicheskaia mikrobiologiia i antimikrobnaia khimioterapiia Pub Date : 2021-01-01 DOI:10.36488/cmac.2021.3.248-253

E. A. Ortenberg

{"title":"COVID-19近两年:抗生素使用的某些方面","authors":"E. A. Ortenberg","doi":"10.36488/cmac.2021.3.248-253","DOIUrl":null,"url":null,"abstract":"The objective of this review was to summarize impact of the widespread administration of antibiotics in treatment algorithms for patients with COVID-19 on treatment outcomes. The experience of antimicrobial use agents during COVID-19 pandemic did not show any life-saving effect. It justifies a need to limit their administration to COVID-19 patients.","PeriodicalId":53392,"journal":{"name":"Klinicheskaia mikrobiologiia i antimikrobnaia khimioterapiia","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Almost two years with COVID-19: some aspects of antibiotic use\",\"authors\":\"E. A. Ortenberg\",\"doi\":\"10.36488/cmac.2021.3.248-253\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The objective of this review was to summarize impact of the widespread administration of antibiotics in treatment algorithms for patients with COVID-19 on treatment outcomes. The experience of antimicrobial use agents during COVID-19 pandemic did not show any life-saving effect. It justifies a need to limit their administration to COVID-19 patients.\",\"PeriodicalId\":53392,\"journal\":{\"name\":\"Klinicheskaia mikrobiologiia i antimikrobnaia khimioterapiia\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Klinicheskaia mikrobiologiia i antimikrobnaia khimioterapiia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36488/cmac.2021.3.248-253\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klinicheskaia mikrobiologiia i antimikrobnaia khimioterapiia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36488/cmac.2021.3.248-253","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 1

摘要

本综述的目的是总结COVID-19患者治疗算法中广泛使用抗生素对治疗结果的影响。在COVID-19大流行期间使用抗微生物药物的经验没有显示出任何挽救生命的效果。这证明有必要将它们的使用限制在COVID-19患者身上。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Almost two years with COVID-19: some aspects of antibiotic use

The objective of this review was to summarize impact of the widespread administration of antibiotics in treatment algorithms for patients with COVID-19 on treatment outcomes. The experience of antimicrobial use agents during COVID-19 pandemic did not show any life-saving effect. It justifies a need to limit their administration to COVID-19 patients.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Klinicheskaia mikrobiologiia i antimikrobnaia khimioterapiia Medicine-Epidemiology

CiteScore

0.90

自引率

0.00%

发文量

审稿时长

8 weeks